Instrument Inactif

Communiqués Cosmo Pharmaceuticals S.p.A Swiss Exchange

Actions

IT0004167463

Cours en clôture Swiss Exchange Autres places de cotation
- ^CHF	-

29/04	Cosmo pourra publier ses résultats 2023 définitifs d'ici au 31 mai	AW
26/04	Cosmo Pharmaceuticals N.V. annonce des changements exécutifs lors de la prochaine assemblée générale annuelle du 24 mai 2024	CI

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Cosmo Pharmaceuticals N : EGM – 5 July 2024 – Written Proxy	06/06	PU
Cosmo Pharmaceuticals N : EGM – 5 July 2024 – Proposed Amendments to the Renumeration Policy	06/06	PU
Cosmo Pharmaceuticals N : EGM – 5 July 2024 – Notification of number of shares as of 6 June 2024	06/06	PU
Cosmo Pharmaceuticals N : EGM – 5 July 2024 – Explanatory Notes	06/06	PU
Cosmo Pharmaceuticals N : EGM – 5 July 2024 – Convening Notice	06/06	PU
Cosmo Pharmaceuticals N : Written proxy – EGM 5 July 2024	06/06	PU
Cosmo Pharmaceuticals N : Proposed Amendments to the Remuneration Policy – EGM 5 July 2024	06/06	PU
Cosmo Pharmaceuticals N : Notification of number of shares 6 June 2024 – EGM 5 July 2024	06/06	PU
Cosmo Pharmaceuticals N : Explanatory notes – EGM 5 July 2024	06/06	PU
Cosmo Pharmaceuticals N : Convening notice – EGM 5 July 2024	06/06	PU
Cosmo to Bring Real-Time AI into Intelligent Medical Devices with NVIDIA IGX	03/06	NE
Cosmo Reports Excellent Final Full Year 2023 Financial Results - Increases Operating Profit Guidance for 2024 - Dividend of 2.00 per Share Will Be Proposed at EGM on 5 July 2024	01/06	NE
Cosmo Pharmaceuticals N : reports excellent final Full Year 2023 financial results – Increases operating profit guidance for 2024 – Dividend of € 2.00 per share will be proposed at EGM on 5 July 2024	31/05	PU
Cosmo Pharmaceuticals' Shareholders Approve All Agenda Items at Annual General Meeting	24/05	NE
Cosmo Pharmaceuticals N : ’ Shareholders approve all Agenda Items at Annual General Meeting	24/05	PU
Cosmo Pharmaceuticals N : Niall Donnelly CV	09/05	PU
Cosmo Pharmaceuticals N : Convening notice	09/05	PU
Cosmo Pharmaceuticals N : Written Proxy	09/05	PU
Cosmo Pharmaceuticals N : Explanatory notes	09/05	PU
Cosmo Pharmaceuticals N : Notification of number of shares	09/05	PU

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Cosmo Pharmaceuticals S.p.A Swiss Exchange

Actions

IT0004167463

Communiqués

Filtres